Bermeo LA, Velasco DV

Idioma: Español
Referencias bibliográficas: 45
Paginas: 60-69
Archivo PDF: 201.59 Kb.

RESUMEN

El asma es un problema de salud de gran importancia a nivel mundial. Desgraciadamente, el diagnóstico y manejo del asma son heterogéneos y en muchos casos inadecuados, con la consiguiente disminución en la calidad de vida y aumento en el costo económico, el sufrimiento, así como en la mortalidad. La presente guía pretende proveernos de herramientas diagnóstico-terapéuticas de calidad a fin de enfrentar de manera adecuada este padecimiento.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Consenso Mexicano de Asma; Neumología y Cirugía de Tórax: 2005; 64 (S1): S7-S44.

2. Cano AG, González MJ, Herrero LA, Martín MJ. Asma y crisis asmática. Principios de urgencias, Emergencias y cuidados críticos 2009. www.uninet.edu/tratado/c0207i.htlm

3. Busey JF, Fenger EP, Hepper NG. Management of status asthmaticus. A statement by the Committee on Therapy. Am Rev Respir Dis 1968; 97: 735-736.

4. Guía Española para el Manejo del Asma. Gema, 2009.

5. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168: 740-759.

6. The Global Burden of Asthma Report. GINA 2007. www.ginasthma.org

7. Braman, SS. Asthma in the elderly. Clin Geriatr Med 2003; 19: 57-75.

8. Tschopp JM, Sistek D, Schindler Ch, Leuenberger Ph, Perruchoud AP, Wüthrich B et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8,329 randomized adults from the SAPALDIA study. Allergy 1998; 53: 608-613.

9. Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C et al. A systematic review of the diagnosis of occupational asthma. Chest 2007; 131: 569-578.

10. GINA 2002. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Report. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. Publication 02-3659.

11. NAEPP 2002. Nacional Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: Expert Panel Report 2. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. Publication 97-4051.

12. Plaza V, Álvarez FJ, Casan P, Cobos N, López VA et al. En calidad de Comité Ejecutivo de la GEMA y en representación del grupo de redactores. Guía Española para el Manejo del Asma (GEMA 2003). Arch Bronconeumol 2003; 39(Suppl 5): 1-42.

13. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol 1995; 75(1): 41-47.

14. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Sys Rev 2006; 2: CD000052.

15. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2000: 2.

16. Hasegawa T, Ishihara K, Takakura S, Fujii H, Nishimura T, Okazaki M et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation: a randomized study. Intern Med 2000; 39(10): 794-797.

17. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbation of asthma (Cochrane Review). London: John Wiley & Sons Ltd. The Cochrane Library. 2001; 3.

18. Rowe BH, Spooner CH, Ducharme FM, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Sys Rev 2007; 3: CD000195.

19. Osman LM, Calder C, Godden DJ, Friend JA, McKenzie L, Legge JS et al. A randomized trial of self-management planning for adult patients admitted to hospital with acute asthma. Thorax 2002; 57: 869-74.

20. Rodrigo GJ, Rodríguez-Verde M, Peregalli V, Rodrigo C. Effects of short term 28% and 100% oxygen in PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003; 124: 1312-1317.

21. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113: 593-598.

22. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Syst Rev 2003; 4: CD001115.

23. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database of Sys Rev 2001; 2: CD002988.

24. Rubinfeld AR, Scicchitano R, Hunt A, Thompson PJ, van Nooten A, Selroos O. Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J 2006; 27: 735-741.

25. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740-746.

26. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Sys Rev 2001; 1: CD002178.

27. Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006; 130: 1301-1311.

28. Rodrigo GJ, Nannini LJ. Is there a place for nebulized magnesium sulfate in the treatment of acute asthma? A systematic review. Curr Ther 2006; 1: 181-185.

29. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Sys Rev 2000; 2: CD001490.

30. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Sys Rev 2000; 4: CD002742.

31. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Sys Rev 2006; 4: CD002884.

32. Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150: 870-874.

33. Strauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr. Observations of the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155: 454-458.

34. Grunfeld A, Fitzgerald JM. Discharge considerations in acute asthma. Can Respir J 1996; 3: 322-324.

35. Udwadia ZF, Harrison BD. An attempt to determine the optimal duration of hospital stay following a severe attack of asthma. J R Coll Physicians Lond 1990; 24: 112-114.

36. Pearson MG, Ryland I, Harrison BD. National audit of acute severe asthma in adults admitted to hospital. Standards of Care Committee, British Thoracic Society. Qual Health Care 1995; 4: 24-30.

37. Rodrigo GJ, Rodrigo C, Nannini LJ. Asma fatal o casi fatal: ¿entidad clínica o manejo inadecuado? Arch bronconeumol 2004; 40: 24-33.

38. Hall JB, Wood L. Status asthmaticus. In: Hall JB, Schmidt GA, Wood L, eds: Principles of Critical Care. New York: McGraw-Hill, 1992; 1670-1679.

39. Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129: 385-387.

40. Tuxen DV. Permissive hypercapnia. In: Tobin MJ. Principles and practice of mechanical ventilation. New York: McGraw-Hill, New York, 1994; 371-392.

41. Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24: 379-380.

42. Perret C, Feihl F. Respiratory failure in asthma: Management of the mechanically ventilated patient. In: Vincent JL, ed: 1992 Yearbook of Intensive Care and Emergency Medicine. Berlín, Springer-Verlag, 1992; 364-371.

43. Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24: 379-380.

44. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989; 140: 5-9.

45. Limthongkul S, Udompanich V, Wongthim S et al. Status asthmaticus: an analysis of 560 episodes and comparison between mechanical and non-mechanical ventilation groups. J Med Assoc Thai 1990; 73: 495-501.